Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
1
–
15
of
749
results
| Purity or Quality Grade | >98% by SDS-PAGE and HPLC |
|---|---|
| Conjugate | Unconjugated |
| Form | Liquid |
| Molecular Weight (g/mol) | 25.4 kDa |
| Formulation | 0.12% acetic acid with 20% ethanol and no preservative |
| Endotoxin Concentration | <0.1 ng/ μg |
| Sequence | Human TGF-beta 3 recombinant protein is a homodimer containing two 112 amino acid subunits |
| For Use With (Application) | Control,ELISA,Functional Assay,Immunohistochemistry,Western Blot |
| Source | Human |
| Name | Human TGF-beta 3 |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥95% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 25 kDa |
| Common Name | TGF beta-1 |
| Gene Symbol | Tgfb1 |
| Activity | ED50 < 0.2 ng/mL; determined by the dose-dependent inhibition of mouse HT-2 cells stimulated with mouse IL-4. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | 4°C |
| Sequence | Human TGF-beta 1 recombinant protein is a homodimer containing two 112 amino acid subunits |
| Expression System | HEK293 cells |
| For Use With (Application) | Bioactivity |
| Name | Human TGF-beta 1 |
| Accession Number | P01137 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
| Product Type | Protein |
| Gene ID (Entrez) | 7040 |
| Formulation | 100mM acetic acid with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | >98% by SDS-PAGE and HPLC |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 8 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 18.3 kDa |
| Common Name | TNFR1 |
| Gene Symbol | Tnfrsf1a |
| Activity | ED50 = 0.05 μg/mL; determined by the dose-dependent inhibition of TNF-alpha (0.25 ng/mL) mediated cytotoxicity in mouse L-929 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | Human TNF-RI recombinant protein contains 162 amino acids |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human TNF-RI (soluble) |
| Accession Number | P19438 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CD120a; CD120a antigen; FPF; hypothetical protein; metalloproteinase inhibitor 4; MGC19588; MS5; n-smase activation assoc. factor; p55; p55 TNF receptor; p55-R; p60; p62; p63; sCD120a; soluble CD120a; soluble TNFR1; sTNF RI; sTNFR I; sTNFR1; sTNFRI; TBP1; TBPI; TIMP metallopeptidase inhibitor 4; Timp4; TIMP-4; tissue inhibitor of metalloproteinase 4; tissue inhibitor of metalloproteinases 4; TNF receptor alpha chain; TNF receptor superfamily member 1A; TNF-alphaR1; TNF-alpha-R1; TNFalpha-R1; TNFAR; TNFR; TNF-R; TNFR I; TNFR1; TNF-R1; Tnfr-1; TNFR1-d2; Tnfr-2; TNFR55; TNF-R55; TNFR60; TNFRI; TNF-RI; TNF-R-I; TNFR-I; TNFRp55; Tnfrsf1a; tumor necrosis factor binding protein 1; Tumor necrosis factor receptor; tumor necrosis factor receptor 1; tumor necrosis factor receptor 1A isoform beta; tumor necrosis factor receptor superfamily member 1A; Tumor necrosis factor receptor superfamily member 1A, membrane form; tumor necrosis factor receptor superfamily, member 1A; tumor necrosis factor receptor type 1; tumor necrosis factor receptor type I; tumor necrosis factor-alpha receptor; Tumor necrosis factor-binding protein 1 |
| Product Type | Protein |
| Gene ID (Entrez) | 7132 |
| Formulation | 5mM tris with no preservative; pH 8 |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥95% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 5 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 17 kDa |
| Common Name | FGF2 |
| Gene Symbol | FGF2 |
| Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | PALPEDGGSG AFPPGHFKDP KRLYCKNGGF FLRIHPDGRV DGVREKSDPH IKLQLQAEER GVVSIKGVCA NRYLAMKEDG RLLASKCVTD ECFFFERLES NNYNTYRSRK YTSWYVALKR TGQYKLGSKT GPGQKAILFL PMSAKS |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-basic (FGF-2/bFGF) (aa 10-155) |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Product Type | Protein |
| Gene ID (Entrez) | 2247 |
| Formulation | 20mM citrate with no preservative; pH 5 |
| Recombinant | Recombinant |
| Purity or Quality Grade | >95% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 17 kDa |
| Common Name | FGF2 |
| Gene Symbol | FGF2 |
| Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | 4°C |
| Sequence | Human FGF-basic, amino acids 10-155 |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-basic (FGF-2/bFGF) (aa 10-155) |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Product Type | Protein |
| Gene ID (Entrez) | 2247 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | >95% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 25.4 kDa |
| Common Name | PDGF-BB |
| Gene Symbol | PDGFB |
| Activity | ED50 ≤ 5 ng/mL; determined by the dose-dependent proliferation of BALB/c 3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | 4°C |
| Sequence | SLGSLTIAEP AMIAECKTRT EVFEISRRLI DRTNANFLVW PPCVEVQRCS GCCNNRNVQC RPTQVQLRPV QVRKIEIVRK KPIFKKATVT LEDHLACKCE TVAAARPVT |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human PDGF-BB |
| Accession Number | P01127 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | becaplermin; c-sis; FLJ12858; H-PDGF-BB; IBGC5; PDGF; pdgf protein; PDGF subunit B; PDGF, B chain; PDGF2; PDGF-2; PDGFB; PDGF-B; platelet derived growth factor subunit B; platelet derived growth factor, B polypeptide; platelet-derived growth factor 2; platelet-derived growth factor B; platelet-derived growth factor B chain; platelet-derived growth factor beta; platelet-derived growth factor beta polypeptide; platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog); platelet-derived growth factor subunit B; platelet-derived growth factor, beta polypeptide (oncogene SIS); Platelet-derived growth factor, same as Sis (Simian sarcoma viral oncogene homologue, c-sis); proto-oncogene c-Sis; Sis; SSV |
| Product Type | Protein |
| Gene ID (Entrez) | 5155 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥98% by SDS-PAGE and HPLC |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 7.5 kDa |
| Common Name | IGF1 |
| Gene Symbol | IGF1 |
| Activity | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of FDC-P1 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPAKSA |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human IGF-I |
| Accession Number | P05019 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | C730016P09Rik; class 1 insulin-like growth factor I preproprotein; class 2 insulin-like growth factor I preproprotein; H-IGF-1; IBP1; IGF; IGF1; Igf-1; IGF1A; IGFI; Igf-I; IGFIa; IGF-IA; IGF-IB; insulin growth factor-1; Insulin like growth factor; insulin like growth factor 1; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor I (somatomedin C); insulin-like growth factor IB; mechano growth factor; MGF; M-IGF-1; OTTHUMP00000195084; prepro-IGF-I; prepro-insulin-like growth factor I; R-IGF-1; somatomedin; Somatomedin C; Somatomedin-C |
| Product Type | Protein |
| Gene ID (Entrez) | 3479 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥95% by SDS-PAGE and HPLC |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.2 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 18.7 kDa |
| Common Name | FGF6 |
| Gene Symbol | FGF6 |
| Activity | ED50 ≤ 0.1 ng/mL; determined by the dose-dependent proliferation of Balb/c 3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | Human FGF-6 recombinant protein contains 168 amino acids |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-6 |
| Accession Number | P10767 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | FGF; FGF6; Fgf-6; Fibroblast growth factor; Fibroblast growth factor 6; HBGF-6; Heparin secretory-transforming protein 2; heparin-binding growth factor 6; HST2; HST-2; Hstf2; HSTF-2 |
| Product Type | Protein |
| Gene ID (Entrez) | 2251 |
| Formulation | 10mM sodium phosphate with 50mM NaCl and no preservative; pH 7.2 |
| Recombinant | Recombinant |
| Purity or Quality Grade | >95% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 8 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 21.2 kDa |
| Common Name | FGF18 |
| Gene Symbol | Fgf18 |
| Activity | ED50 ≤ 10 ng/mL; determined by the dose-dependent proliferation of Balb/c 3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | Human FGF-18 recombinant protein contains 173 amino acids |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-18 |
| Accession Number | O76093 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | D130055P09Rik; FGF; FGF18; FGF-18; Fibroblast growth factor; Fibroblast growth factor 18; UNQ420/PRO856; zFGF5 |
| Product Type | Protein |
| Gene ID (Entrez) | 8817 |
| Formulation | 10mM tris with no preservative; pH 8 |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥95% by SDS-PAGE and HPLC |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 19.3 kDa |
| Common Name | FGF10 |
| Gene Symbol | FGF10 |
| Activity | ED50 = 0.5 - 15 ng/mL; determined by the dose-dependent proliferation of 4MBr-5 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | Human FGF-10 recombinant protein contains 170 amino acids |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-10 |
| Accession Number | O15520 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | AEY17; BB213776; FGF; Fgf10; FGF-10; Fibroblast growth factor; Fibroblast growth factor 10; Gsfaey17; Keratinocyte growth factor 2; produced by fibroblasts of urinary bladder lamina propria |
| Product Type | Protein |
| Gene ID (Entrez) | 2255 |
| Formulation | 5mM sodium phosphate with 80mM NaCl and no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | >95% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 17.2 kDa |
| Common Name | FGF2 |
| Gene Symbol | FGF2 |
| Activity | ED50 = 0.1 - 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | 4°C |
| Sequence | Human FGF-basic, amino acids Met134-Ser288 with C211S and C229S substitutions and an N-terminal Gly-His |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-basic (FGF-2/bFGF) (aa 1-155) |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Product Type | Protein |
| Gene ID (Entrez) | 2247 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Buffer | 750 mM NaCl, 20 mM Na2PO4 |
|---|---|
| Content And Storage | -20°Cor to +80°C if preferred |
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF10 |
| Activity | ED50 ≤1.0 ng/mL; measured in a cell proliferation assay using 4 MBr-5 cells |
| Endotoxin Concentration | 0.25 EU/μg |
| Sequence | Thermostable variant of human FGF-10 (190 amino acids) with proprietary amino acid substitutions |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Heat Stable FGF-10 |
| Accession Number | O15520 |
| Purification Method | SDS-Page |
| Gene Alias | AEY17; BB213776; FGF; Fgf10; FGF-10; Fibroblast growth factor; Fibroblast growth factor 10; Gsfaey17; Keratinocyte growth factor 2; produced by fibroblasts of urinary bladder lamina propria |
| Product Type | Protein |
| Biological Activity | ED50 = 1.0 ng/mL; measured in a cell proliferation assay using 4 MBr-5 cells |
| Gene ID (Entrez) | 2255 |
| Formulation | protein with 20 mM Na2PO4, 750 mM NaCl and no preservative; pH 7.5 |
| Classification | Recombinant |
| Species | Human |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥95% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 25 kDa |
| Common Name | TGF beta-1 |
| Gene Symbol | Tgfb1 |
| Activity | ED50 < 0.2 ng/mL; determined by the dose-dependent inhibition of mouse HT-2 cells stimulated with mouse IL-4. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | 4°C |
| Sequence | Human TGF-beta 1 recombinant protein is a homodimer containing two 112 amino acid subunits |
| Expression System | HEK293 cells |
| For Use With (Application) | Bioactivity |
| Name | Human TGF-beta 1 |
| Accession Number | P01137 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
| Product Type | Protein |
| Gene ID (Entrez) | 7040 |
| Formulation | 100mM acetic acid with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥98% by SDS-PAGE and HPLC |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 8 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 18.9 kDa |
| Common Name | TNFR2 |
| Gene Symbol | Tnfrsf1b |
| Activity | ED50 = 0.125 μg/mL; determined by the dose-dependent inhibition of TNF-alpha (0.25 ng/mL) mediated cytotoxicity in mouse L-929 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | Human TNF-RII recombinant protein contains 174 amino acids |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human TNF-RII (soluble) |
| Accession Number | P20333 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CD120b; Etanercept; p75; p75 TNF receptor; p75 TNFR; p75TNFR; p80 TNF-alpha receptor; sCD120b; soluble CD120b; soluble TNFR1B variant 1; soluble TNFR2; sTNF R2; sTNFR 2; sTNFR2; TBP-2; TBPII; TNF receptor beta chain; TNF receptor superfamily member 1B; TNF-alphaR2; TNFalpha-R2; TNFBR; TNFR; TNFR II; Tnfr-1; TNFR1B; TNFR2; TNF-R2; Tnfr-2; TNF-R75; TNFR80; TNFRII; TNF-RII; TNF-R-II; TNFR-II; TNFRSF1B; tumor necrosis factor beta receptor; tumor necrosis factor binding protein 2; Tumor necrosis factor receptor; tumor necrosis factor receptor 2; Tumor necrosis factor receptor superfamily member 1B; Tumor necrosis factor receptor superfamily member 1b, membrane form; tumor necrosis factor receptor superfamily, member 1B; tumor necrosis factor receptor type II; Tumor necrosis factor-binding protein 2 |
| Product Type | Protein |
| Gene ID (Entrez) | 7133 |
| Formulation | 10mM sodium phosphate with 50mM NaCl and no preservative; pH 8 |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥98% by SDS-PAGE and HPLC |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 16.3 kDa |
| Common Name | CD154 (CD40 Ligand) |
| Gene Symbol | CD40LG |
| Activity | ED50 = 5 - 10 ng/mL; determined by the dose-dependent stimulation of IL-8 production by human PBMCs. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | Human CD40 ligand recombinant protein contains 149 amino acids |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human CD40 Ligand (TNFSF5) |
| Accession Number | P29965 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CD154; CD40 antigen ligand; CD40 ligand; CD40 ligand CD154; CD40 ligand, membrane form; CD40 ligand, soluble form; CD40L; CD40-L; Cd40lg; gp39; hCD40L; H-CD-40-L; HIGM1; IGM; IMD3; Ly62; Ly-62; M-CD-40-L; RP23-153G22.3; T-B cell-activating molecule; T-BAM; T-cell antigen Gp39; TNF-related activation protein; TNFSF5; TRAP; tumor necrosis factor (ligand) superfamily member 5; tumor necrosis factor (ligand) superfamily, member 5; tumor necrosis factor ligand superfamily member 5 |
| Product Type | Protein |
| Gene ID (Entrez) | 959 |
| Formulation | 10mM sodium phosphate with no preservative |
| Recombinant | Recombinant |
